Provectus Biopharmaceuticals, Inc.
PVCT- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000315545
No open-market purchases or sales by Provectus Biopharmaceuticals, Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $8.97K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Provectus Biopharmaceuticals, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 6 | 4 | −2 |
| Shares | 202.4K | 129.8K | −72.6K (−35.9%) |
| Value | $10.4K | $8.97K | −$1.41K (−13.6%) |
New holders (0)
Institutions that held Provectus Biopharmaceuticals, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
None.
Sold out (2)
Institutions that held Provectus Biopharmaceuticals, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Wealth Preservation Advisors, LLC | 52,600 | $2.68K |
| Academy Capital Management Inc | 20,000 | $1.02K |